Gemtuzumab: time to bring back on the market?

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)326-327
Number of pages2
JournalClinical advances in hematology & oncology : H&O
Volume10
Issue number5
StatePublished - May 1 2012

Fingerprint

Safety-Based Drug Withdrawals
Antibodies, Monoclonal, Humanized
Aminoglycosides
Acute Myeloid Leukemia
Antineoplastic Agents
Research
gemtuzumab

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gemtuzumab : time to bring back on the market? / Foran, James M.

In: Clinical advances in hematology & oncology : H&O, Vol. 10, No. 5, 01.05.2012, p. 326-327.

Research output: Contribution to journalArticle

@article{22ca9c505dc443c4bb9e299921723554,
title = "Gemtuzumab: time to bring back on the market?",
author = "Foran, {James M}",
year = "2012",
month = "5",
day = "1",
language = "English (US)",
volume = "10",
pages = "326--327",
journal = "Clinical Advances in Hematology and Oncology",
issn = "1543-0790",
publisher = "Millennium Medical Publishing, Inc.",
number = "5",

}

TY - JOUR

T1 - Gemtuzumab

T2 - time to bring back on the market?

AU - Foran, James M

PY - 2012/5/1

Y1 - 2012/5/1

UR - http://www.scopus.com/inward/record.url?scp=84894508098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894508098&partnerID=8YFLogxK

M3 - Article

C2 - 22706544

AN - SCOPUS:84894508098

VL - 10

SP - 326

EP - 327

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 5

ER -